DMD and Duchenne muscular dystrophy: Based on the use of the PB transposon system, the genes encoding either full-length human dystrophin or truncated microdystrophins could be successfully introduced into myoblasts and expressed in differentiated multinucleated myotubules [151], paving the way toward a PB-mediated gene therapy approach for Duchenne muscular dystrophy (DMD).